# Real-World Effectiveness of Ritlecitinib in Alopecia Areata Patients in the US: A Retrospective Analysis Using EHR and Claims Data

> **NCT07821216** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 7500 (estimated)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** ritlecitinib

## Key facts

- **NCT ID:** NCT07821216
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-08-17
- **Primary completion:** 2027-04-20
- **Final completion:** 2027-04-20
- **Target enrollment:** 7500 (ESTIMATED)
- **Last updated:** 2026-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07821216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07821216, "Real-World Effectiveness of Ritlecitinib in Alopecia Areata Patients in the US: A Retrospective Analysis Using EHR and Claims Data". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07821216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
